ProfileGDS4718 / 213505_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 84% 88% 86% 87% 90% 92% 83% 84% 86% 84% 86% 86% 86% 91% 86% 85% 83% 89% 94% 83% 83% 84% 85% 84% 88% 86% 90% 87% 91% 85% 90% 83% 81% 86% 88% 88% 85% 86% 87% 84% 88% 87% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6624486
GSM549102patient 115, normal, homogenized [OPG study]8.2327984
GSM549104patient 119, normal, homogenized [OPG study]8.9446988
GSM549108patient 138, normal, homogenized [OPG study]8.4867486
GSM549119patient 077, normal, homogenized [OPG study]8.7373787
GSM549133patient 032, cancer, homogenized [OPG study]9.2165590
GSM549139patient 042, cancer, homogenized [OPG study]9.4793792
GSM549099patient 107, normal, homogenized [OPG study]8.1790683
GSM549109patient 139, normal, homogenized [OPG study]8.328484
GSM549110patient 046, normal, homogenized [OPG study]8.5655486
GSM549114patient 063, normal, homogenized [OPG study]8.4764484
GSM549122patient 082, normal, homogenized [OPG study]8.5598886
GSM549134patient 033, cancer, homogenized [OPG study]8.6243386
GSM549136patient 036, cancer, homogenized [OPG study]8.7113186
GSM549140patient 044, cancer, homogenized [OPG study]9.3278391
GSM549111patient 047, normal, homogenized [OPG study]8.715686
GSM549113patient 057, normal, homogenized [OPG study]8.6077585
GSM549132patient 031, cancer, homogenized [OPG study]8.2078183
GSM549137patient 038, cancer, homogenized [OPG study]9.0211789
GSM549142patient 047, cancer, homogenized [OPG study]9.4956994
GSM549100patient 110, normal, homogenized [OPG study]8.0882983
GSM549107patient 135, normal, homogenized [OPG study]8.2560183
GSM549115patient 068, normal, homogenized [OPG study]8.5245884
GSM549116patient 072, normal, homogenized [OPG study]8.5838185
GSM549120patient 078, normal, homogenized [OPG study]8.3985784
GSM549131patient 030, cancer, homogenized [OPG study]8.9804388
GSM549118patient 074, normal, homogenized [OPG study]8.5995286
GSM549129patient 027, cancer, homogenized [OPG study]9.1007990
GSM549123patient 088, normal, homogenized [OPG study]8.7445787
GSM549124patient 006, cancer, homogenized [OPG study]9.2401591
GSM549126patient 015, cancer, homogenized [OPG study]8.4377485
GSM549128patient 025, cancer, homogenized [OPG study]9.2197590
GSM549103patient 117, normal, homogenized [OPG study]8.0803383
GSM549117patient 073, normal, homogenized [OPG study]8.0481581
GSM549138patient 041, cancer, homogenized [OPG study]8.6169886
GSM549141patient 045, cancer, homogenized [OPG study]9.0050188
GSM549130patient 028, cancer, homogenized [OPG study]8.8132388
GSM549101patient 111, normal, homogenized [OPG study]8.4328885
GSM549105patient 128, normal, homogenized [OPG study]8.6065186
GSM549106patient 134, normal, homogenized [OPG study]8.9155687
GSM549112patient 048, normal, homogenized [OPG study]8.3666584
GSM549125patient 011, cancer, homogenized [OPG study]8.7597588
GSM549127patient 024, cancer, homogenized [OPG study]8.6412587
GSM549135patient 035, cancer, homogenized [OPG study]8.8213987